NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT
CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
CINCINNATI, Ohio, May 10, 2018 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSX-V:PHM), a
healthcare services company with operations in the U.S., today announced that it will host its Quarterly Conference Call on
Tuesday, May 15th, 2018 at 4:30 p.m. EST.
Conference Call Details:
Tuesday May 15, 2018 at 4:30 p.m. EDT.
US Toll Free: 866-454-4207
Canada Toll Free: +1 647 794 1826
Participant Passcode: 357916
ABOUT PROTECH HOME MEDICAL
The Company provides in-home monitoring and disease management services for patients in the United States
healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states
focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The
initial service line includes providing in-home monitoring equipment, supplies and services to patients in the U.S. who take
prescription blood thinners, such as Coumadin® (warfarin).
The primary business objective of the Company is to create shareholder value by offering a broader range of
services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to
increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and
making life easier for the patient.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information please visit our website at www.phmcompanies.com, or contact:
Greg Crawford
CEO/Chairman
Protech Home Medical Corp.
859-300-6455
investorinfo@myphm.com
